Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-21-008421
Filing Date
2021-11-15
Accepted
2021-11-15 17:26:08
Documents
119
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm   iXBRL 10-Q 1666476
2 CERTIFICATION curr_ex311.htm EX-31.1 11251
3 CERTIFICATION curr_ex312.htm EX-31.2 11969
4 CERTIFICATION curr_ex321.htm EX-32.1 4888
5 CERTIFICATION curr_ex322.htm EX-32.2 4760
  Complete submission text file 0001477932-21-008421.txt   9571459

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA curr-20210930.xsd EX-101.SCH 124359
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20210930_lab.xml EX-101.LAB 584624
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20210930_cal.xml EX-101.CAL 79509
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20210930_pre.xml EX-101.PRE 518472
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20210930_def.xml EX-101.DEF 313192
11 EXTRACTED XBRL INSTANCE DOCUMENT curr_10q_htm.xml XML 1789504
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 211412692
SIC: 2834 Pharmaceutical Preparations